Pharmacokinetics of motilin in man. 1977

P Mitznegg, and S R Bloom, and W Domschke, and S Domschke, and E Wuensch, and L Demling

The study provides pharmacokinetic data for exogenous synthetic and endogenous natural motilin in man. Synthetic 13-norleucine-motilin was infused into 6 healthy volunteers at a dose of 0.6 and 2.4 (pmoles per kg) per min over 60 min and plasma motilin was measured by radioimmunoassay. During the infusions mean plasma levels of 124.8 +/- 14.8 and 360 +/- 19.6 pmoles per liter, respectively, were achieved. Disappearance half-time on stopping the infusion was 4.36 min. The apparent volume of distribution was calculated to be 49.4 +/- 3.3 ml per kg, and the metabolic clearance rate was 7.8 +/- 0.5 (ml per kg) per min. To measure the decay of endogenous motilin somatostatin was used in the same 6 subjects. A bolus of 100 mug and a subsequent 15-min infusion of 15 mug per min of somatostatin suppressed the fasting motilin level by 50%. The disappearance half-time was 4.56 min. It is concluded that both synthetic and endogenous motilin are eliminated by first order kinetics with very similar half-times. Our data also suggest that the previously reported motilin infusions at these dose levels gave plasma concentrations within the physiological range and that the effects noted may thus have reflected the physiological actions of motilin.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D009037 Motilin A peptide of about 22-amino acids isolated from the DUODENUM. At low pH it inhibits gastric motor activity, whereas at high pH it has a stimulating effect.
D009646 Norleucine An unnatural amino acid that is used experimentally to study protein structure and function. It is structurally similar to METHIONINE, however it does not contain SULFUR. Norleucine, L-Isomer,L-Isomer Norleucine,Norleucine, L Isomer
D005768 Gastrointestinal Hormones HORMONES secreted by the gastrointestinal mucosa that affect the timing or the quality of secretion of digestive enzymes, and regulate the motor activity of the digestive system organs. Enteric Hormone,Enteric Hormones,Gastrointestinal Hormone,Intestinal Hormone,Intestinal Hormones,Hormone, Enteric,Hormone, Gastrointestinal,Hormone, Intestinal,Hormones, Enteric,Hormones, Gastrointestinal,Hormones, Intestinal
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Mitznegg, and S R Bloom, and W Domschke, and S Domschke, and E Wuensch, and L Demling
July 1987, The Tohoku journal of experimental medicine,
P Mitznegg, and S R Bloom, and W Domschke, and S Domschke, and E Wuensch, and L Demling
February 2016, Gut,
P Mitznegg, and S R Bloom, and W Domschke, and S Domschke, and E Wuensch, and L Demling
December 1983, Gastroenterologia Japonica,
P Mitznegg, and S R Bloom, and W Domschke, and S Domschke, and E Wuensch, and L Demling
December 1980, Endocrinologia japonica,
P Mitznegg, and S R Bloom, and W Domschke, and S Domschke, and E Wuensch, and L Demling
July 1979, Digestive diseases and sciences,
P Mitznegg, and S R Bloom, and W Domschke, and S Domschke, and E Wuensch, and L Demling
February 1979, Gut,
P Mitznegg, and S R Bloom, and W Domschke, and S Domschke, and E Wuensch, and L Demling
June 1980, European journal of clinical investigation,
P Mitznegg, and S R Bloom, and W Domschke, and S Domschke, and E Wuensch, and L Demling
January 1997, Peptides,
P Mitznegg, and S R Bloom, and W Domschke, and S Domschke, and E Wuensch, and L Demling
January 1980, The Journal of international medical research,
P Mitznegg, and S R Bloom, and W Domschke, and S Domschke, and E Wuensch, and L Demling
January 1971, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!